Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rugge, M
Right arrow Articles by Egarter-Vigl, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rugge, M
Right arrow Articles by Egarter-Vigl, E
J Clin Pathol: Mol Pathol 2000; 53:207-210
© 2000 Journal of Clinical Pathology

The p53 gene in patients under the age of 40 with gastric cancer: mutation rates are low but are associated with a cardiac location

M Rugge1, Y-H Shiao2, G Busatto1, M Cassaro1, C Strobbe1, V M Russo1, G Leo1, A R Parenti1, A Scapinello3, P Arslan4 and E Egarter-Vigl5

1 Department of Oncology and Surgical Sciences, University of Padova, ULSS15-Regione Veneto, Via A Gabelli 61, 35121, Padova, Italy
2 Laboratory of Comparative Carcinogenesis, NCI-FCRDC, NIH, Frederick, MD 21702, USA
3 Department of Pathology, Castelfranco Veneto Hospital, 31033 Bassano, Italy
4 Department of Medical and Diagnostic Sciences, University of Padova, 35121 Padova, Italy
5 Department of Pathology, Bolzano General Hospital, 39100 Bolzano, Italy

Correspondence: Dr Rugge email: rugge{at}ux1.unipd.it

Background—Determining both the frequency and the spectrum of p53 gene mutation in young patients with gastric cancer might provide clues to the host related genetic mechanism(s) in gastric carcinogenesis.

Patients and methods—p53 mutations were assessed (by means of polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP), followed by DNA sequencing) in a cohort of 105 consecutive Italian patients in whom gastric cancer was ascertained before the age of 41.

Results—A low prevalence of p53 mutations (eight of 105) was observed, with no significant difference between intestinal (three of 31; 10%) and diffuse (five of 74; 7%) phenotypes. A significantly higher prevalence of p53 mutations was associated with the cardiac location (odds ratio, 7.09; confidence interval, 1.56 to 32.11). In all but one case, p53 mutations were associated with a stage higher than I. All eight mutations were located at CpG sites, where G : C to A : T transitions have been associated with frequent methylation at the C5 position of cytosine.

Conclusions—These findings show that, unlike what has been consistently demonstrated in the general population, p53 mutations are uncommon in gastric cancer occurring in young patients, and in such patients, p53 alterations are significantly associated with the cardiac location.

Key Words: stomach neoplasm • genes • p53




This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
A N A Milne, R Carvalho, M Jansen, E K Kranenbarg, C J H van de Velde, F M Morsink, A R Musler, M A J Weterman, and G J A Offerhaus
Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival
J. Clin. Pathol., March 1, 2008; 61(3): 311 - 316.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Yamada, K. Shinmura, K. Okudela, M. Goto, M. Suzuki, K. Kuriki, T. Tsuneyoshi, and H. Sugimura
Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population
Carcinogenesis, September 1, 2007; 28(9): 2013 - 2018.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. Ohmiya, A. Taguchi, N. Mabuchi, A. Itoh, Y. Hirooka, Y. Niwa, and H. Goto
MDM2 Promoter Polymorphism Is Associated With Both an Increased Susceptibility to Gastric Carcinoma and Poor Prognosis
J. Clin. Oncol., September 20, 2006; 24(27): 4434 - 4440.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
B G Schneider, S Y Rha, H C Chung, J C Bravo, R Mera, J C Torres, K T Plaisance Jr, R Schlegel, C M McBride, X T Reveles, et al.
Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer
Mol. Pathol., June 1, 2003; 56(3): 141 - 149.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Shibata, J. Parsonnet, T. A. Longacre, M. I. Garcia, B. Puligandla, R.E. Davis, J. H. Vogelman, N. Orentreich, and L. A. Habel
CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma
Carcinogenesis, March 1, 2002; 23(3): 419 - 424.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Molecular Pathology Journal of Clinical Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.